Search research articles
Contact Us
Filters
Showing results (101-110 of 116) with videos related to
Page
of 12
Sort By:
Neuroscience
|
November 1, 1994
Expression and developmental regulation of Ehk-1, a neuronal Elk-like receptor tyrosine kinase in brain
V Taylor, G C Miescher, S Pfarr, et al.
Journal of Neuroscience Research
|
April 1, 1994
Myelin basic protein content of aggregating rat brain cell cultures treated with cytokines and/or demyelinating antibody: effects of macrophage enrichment
A J Loughlin, P Honegger, M N Woodroofe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 1995
Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients
L M Jost, E Jacky, C Dommann-Scherrer, et al.
Schweizerische Medizinische Wochenschrift
|
June 24, 1989
[High-dosage chemo-radiotherapy with autologous bone marrow transfusion in malignant lymphoma: indications and personal experience]
R A Stahel, L M Jost, J Burger, et al.
European Journal of Cancer & Clinical Oncology
|
January 1, 1987
A randomized study of methotrexate, bleomycin, hydroxyurea with versus without cisplatin in patients with previously untreated and recurrent squamous cell carcinoma of the head and neck
R Abele, H P Honegger, R Grossenbacher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2006
Long-term results of a multicenter SAKK trial on high-dose ifosfamide and doxorubicin in advanced or metastatic gynecologic sarcomas
S Leyvraz, M Zweifel, G Jundt, et al.
Schweizerische Medizinische Wochenschrift
|
May 8, 1993
[5 years of dosage intensification and autologous bone marrow or peripheral stem cell transfusion in malignant lymphoma with a high risk of recurrence]
L M Jost, G Pichert, M Reichlin, et al.
Schweizerische Medizinische Wochenschrift
|
February 11, 1995
[Participation in multicenter studies as quality control in the therapy of Hodgkin disease: an interim report]
A Lohri, S Leyvraz, T Cerny, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2004
Rituximab-EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study
M Jermann, L M Jost, Ch Taverna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 26, 1999
Saturable metabolism of continuous high-dose ifosfamide with mesna and GM-CSF: a pharmacokinetic study in advanced sarcoma patients. Swiss Group for Clinical Cancer Research (SAKK)
T Cerny, S Leyvraz, T von Briel, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 116) with videos related to
Sort By:
Page
of 12
Neuroscience
|
November 1, 1994
Expression and developmental regulation of Ehk-1, a neuronal Elk-like receptor tyrosine kinase in brain
V Taylor, G C Miescher, S Pfarr, et al.
Journal of Neuroscience Research
|
April 1, 1994
Myelin basic protein content of aggregating rat brain cell cultures treated with cytokines and/or demyelinating antibody: effects of macrophage enrichment
A J Loughlin, P Honegger, M N Woodroofe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 1995
Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients
L M Jost, E Jacky, C Dommann-Scherrer, et al.
Schweizerische Medizinische Wochenschrift
|
June 24, 1989
[High-dosage chemo-radiotherapy with autologous bone marrow transfusion in malignant lymphoma: indications and personal experience]
R A Stahel, L M Jost, J Burger, et al.
European Journal of Cancer & Clinical Oncology
|
January 1, 1987
A randomized study of methotrexate, bleomycin, hydroxyurea with versus without cisplatin in patients with previously untreated and recurrent squamous cell carcinoma of the head and neck
R Abele, H P Honegger, R Grossenbacher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2006
Long-term results of a multicenter SAKK trial on high-dose ifosfamide and doxorubicin in advanced or metastatic gynecologic sarcomas
S Leyvraz, M Zweifel, G Jundt, et al.
Schweizerische Medizinische Wochenschrift
|
May 8, 1993
[5 years of dosage intensification and autologous bone marrow or peripheral stem cell transfusion in malignant lymphoma with a high risk of recurrence]
L M Jost, G Pichert, M Reichlin, et al.
Schweizerische Medizinische Wochenschrift
|
February 11, 1995
[Participation in multicenter studies as quality control in the therapy of Hodgkin disease: an interim report]
A Lohri, S Leyvraz, T Cerny, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2004
Rituximab-EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study
M Jermann, L M Jost, Ch Taverna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 26, 1999
Saturable metabolism of continuous high-dose ifosfamide with mesna and GM-CSF: a pharmacokinetic study in advanced sarcoma patients. Swiss Group for Clinical Cancer Research (SAKK)
T Cerny, S Leyvraz, T von Briel, et al.
Page
of 12